Showing results (201-210 of 222) with videos related to

Sort By:
Pageof 23
Endocrine-Related Cancer|August 25, 2012
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinomaRoberto Bellelli, Maria Domenica Castellone, Ginesa Garcia-Rostan, et al.
Thyroid : Official Journal of the American Thyroid Association|July 17, 2021
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody TestsDaniele Cappellani, Giuseppina De Marco, Eleonora Ferrarini, et al.
European Journal of Endocrinology|June 3, 2015
Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancerRossella Elisei, Loredana Lorusso, Paolo Piaggi, et al.
Cancer Research|November 6, 2007
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinomaGiuliana Salvatore, Tito Claudio Nappi, Paolo Salerno, et al.
Thyroid : Official Journal of the American Thyroid Association|December 18, 2012
Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer seriesRaffaele Ciampi, Caterina Mian, Laura Fugazzola, et al.
Clinical Endocrinology|December 3, 2014
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?Cristina Romei, Alessia Tacito, Eleonora Molinaro, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2012
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort studyRossella Elisei, David Viola, Liborio Torregrossa, et al.
Case Reports in Endocrinology|August 18, 2020
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New <i>RET</i> Germline DeletionCarlotta Giani, Teresa Ramone, Cristina Romei, et al.
Endocrine Connections|October 23, 2013
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancerFilomena Cetani, Chiara Banti, Elena Pardi, et al.
International Journal of Cancer|May 9, 2014
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancerMarta Schirripa, Chiara Cremolini, Fotios Loupakis, et al.
Pageof 23